Navigation Links
David Blumenthal and Aneesh Chopra Give Keynote Addresses at AMIA's Conference on Anticipating and Addressing Unintended Consequences of HIT and Policy
Date:9/11/2009

hese systems."

"HIT includes not only the current focus areas of electronic health records (EHRs) and health information exchange (HIE), but also applications and systems that will be used by consumers and other stakeholders such as personal health records (PHRs) and consumer health and chronic disease management tools," stated Nancy M. Lorenzi, PhD, meeting co-chair and Assistant Vice Chancellor for Health Affairs at Vanderbilt University.

"We believe that improving the state of HIT in this country has enormous potential to improve health outcomes and reduce costs. However, we also believe that unintended consequences can and must be anticipated, identified, and addressed in order to maximize the beneficial effects of HIT," commented David W. Bates, MD, MA, AMIA Board Chair.

Participants also considered potential future issues that we might face, especially those due to the convergence of HIT, clinical technologies and devices, and communications capabilities. During plenary sessions and in small discussion groups, they explored successful approaches to anticipating, recognizing/identifying, and addressing potential unintended consequences of HIT as well as potential unintended consequences of HIT policy and legislative efforts. AMIA plans to develop and disseminate materials that synthesize the conference outcomes to help inform policymakers, Congress, and others about the issues related to unintended consequences of HIT design, development, implementation, adoption and use. Recommendations for areas warranting further research and study will also be included. Interim work products and meeting materials are made available on the AMIA web site at: http://www.amia.org/2009healthpolicymeeting.

About AMIA

AMIA is the professional home for biomedical and health
'/>"/>

SOURCE American Medical Informatics Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Allied Worlds David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium
2. Pro Quarterback David Garrard Aims to Score Big For Crohns Disease During the 2009 Football Season
3. Health Expert Dr. David Friedman Reveals Which Sweeteners Are Best
4. Dr. David Okrongly Appointed CEO of Quanterix Corporation
5. Jackson & Coker Names David Booher Vice President of Emergency Medicine Recruitment
6. Phoenix Cardiovascular Surgeon, David J. Caparrelli, M.D. Becomes Member of the Society for Vascular Surgery
7. Re-Envision Your Look: Dr. David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures
8. Huntsville, Alabama Plastic Surgeon David L. Durst, MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market
9. Dr. David Williams Featured on Searchvitaminsupplements.com
10. Cornerstone Therapeutics David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal
11. Coming Clean About The Cleaner - Phoenix Houses Chief Clinical Officer David Deitch on Intervention, and the Recovery Process That Follows
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 1For Millions With Untreated Hearing Loss Holiday Season Can be Especially Difficult 6542 2Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 1Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 2Crosstalk between critical cell signaling pathways holds clues to tumor invasion and metastasis 62132 3Tailor made HIV AIDS treatment closer to reality 62127 1Tailor made HIV AIDS treatment closer to reality 62127 2